Close this search box.
Close this search box.

April 13, 2021

Within3 in Cleveland Business Journal

Within3 CEO Lance Hill talks about business growth during a pandemic, the company’s role in industry discussions around COVID-19, and what keeps him up at night.

Cleveland Business Journal sat down with Within3 CEO Lance Hill to tackle a number of topics in a recent Q&A. Hill discussed the strengths of Cleveland’s life science industry – including the lower cost of entry and increasing access to capital – as well as how he sees the future of Within3 unfolding. As for what keeps him up at night? “Am I doing everything I can think of to grow faster?”

Read the entire article (subscription may be required)

Related Posts:

how AI can help pharma teams

Within3 in PharmExec: how artificial intelligence can help pharma teams collect and analyze data

pharma remote work

Within3 PharmaTimes: how pharma will navigate remote work

tech for pharma oncology

Within3 in HIT Consultant

More insights, direct to your inbox.